Giuseppe Ciaramella
Known title: PresidentCIK: 0001786322
Associated companies
Transaction History
| BEAM | ▼ Sell | Gift | 123,407 | $0 | 9/24/2026 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 6,505 | $4K | 6/17/2026 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 29,000 | $30K | 6/17/2026 | View on chart |
| BEAM | ▼ Sell | Open Market | 11,810 | $290K | 4/1/2026 | View on chart |
| BEAM | ▲ Buy | Grant | 40,000 | $0 | 3/31/2026 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 35,000 | $595K | 2/24/2026 | View on chart |
| BEAM | ▼ Sell | Open Market | 35,000 | $1.1M | 2/24/2026 | View on chart |
| BEAM | ▼ Sell | Open Market | 7,434 | $136K | 4/1/2025 | View on chart |
| BEAM | ▲ Buy | Grant | 35,000 | $0 | 3/31/2025 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 53,500 | $36K | 12/17/2024 | View on chart |
| BEAM | ▼ Sell | Open Market | 51,110 | $1.3M | 11/6/2024 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 27,318 | $18K | 10/14/2024 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 12,979 | $55K | 10/14/2024 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 1,457 | $11K | 10/14/2024 | View on chart |
| BEAM | ▼ Sell | Open Market | 51,110 | $1.3M | 10/14/2024 | View on chart |
| BEAM | ▼ Sell | Open Market | 4,534 | $146K | 4/1/2024 | View on chart |
| BEAM | ▲ Buy | Grant | 35,000 | $0 | 3/31/2024 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 90,900 | $61K | 10/20/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 1,206 | $9K | 7/24/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,206 | $39K | 7/24/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 69,438 | $501K | 7/21/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 21,846 | $158K | 7/21/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 155,324 | $5.0M | 7/21/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,754 | $51K | 4/4/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,918 | $58K | 4/3/2023 | View on chart |
| BEAM | ▲ Buy | Grant | 20,000 | $0 | 3/31/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 9,106 | $6K | 1/3/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,900 | $74K | 1/3/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 4,326 | $18K | 1/3/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 40,297 | $27K | 1/3/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 37,525 | $1.4M | 1/3/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 13,704 | $521K | 1/3/2023 | View on chart |
| BEAM | ▼ Sell | Open Market | 600 | $24K | 1/3/2023 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 4,500 | $3K | 12/30/2022 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 18,211 | $12K | 12/12/2022 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 8,652 | $37K | 12/12/2022 | View on chart |
| BEAM | ▼ Sell | Open Market | 31,699 | $1.3M | 12/12/2022 | View on chart |
| BEAM | ▼ Sell | Open Market | 13,933 | $601K | 12/12/2022 | View on chart |
| BEAM | ▼ Sell | Open Market | 5,383 | $236K | 12/12/2022 | View on chart |
| BEAM | ▲ Buy | Grant | 15,000 | $0 | 3/31/2022 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,859 | $110K | 3/31/2022 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 39,700 | $27K | 12/29/2021 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 2,607 | $19K | 12/22/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 290 | $25K | 12/22/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,101 | $95K | 12/22/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 1,216 | $104K | 12/22/2021 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 25,104 | $181K | 12/21/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 8,648 | $746K | 12/21/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 16,456 | $1.4M | 12/21/2021 | View on chart |
| BEAM | ▼ Sell | Open Market | 4,289 | $365K | 12/20/2021 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 4,289 | $31K | 12/20/2021 | View on chart |
| BEAM | ▲ Buy | Option Exercise | 18,012 | $12K | 9/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Beam Therapeutics to present BEAM-301 data at ESGCT congress
Beam Therapeutics is scheduled to present initial data from its Phase 1/2 trial of BEAM-301 for Glycogen Storage Disease Type Ia at the 33rd Annual Congress of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. This upcoming presentation is a key catalyst for the stock, which is currently trading near the lower end of its 52-week range. The company is also highlighted in a list of high-beta stocks where short sellers are active, suggesting elevated volatility potential around the data release.
Beam Therapeutics to present BEAM-301 data at ESGCT congress. Beam Therapeutics is scheduled to present initial data from its Phase 1/2 trial of BEAM-301 for Glycogen Storage Disease Type Ia at the 33rd Annual Congress of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. This upcoming presentation is a key catalyst for the stock, which is currently trading near the lower end of its 52-week range. The company is also highlighted in a list of high-beta stocks where short sellers are active, suggesting elevated volatility potential around the data release.